A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn

Aliment Pharmacol Ther. 2004 Nov 1;20(9):975-82. doi: 10.1111/j.1365-2036.2004.02217.x.

Abstract

Background: The rapid onset and symptomatic response to histamine-2 receptor antagonists prior to the pharmacological effect on acid secretion suggests a different mechanism of action.

Aim: To determine if ranitidine decreases oesophageal sensitivity to chemical and mechanical stimulation, potentially via oesophageal histamine receptors.

Methods: A total of 18 patients with functional heartburn received oral ranitidine 150 mg b.d. or placebo for 7 consecutive days in a double-blind randomized crossover design and underwent Barostat balloon distention and Bernstein acid infusion on study day 1 (90 min postdose) and study day 7. First sensation and pain were recorded and pain severity was rated on a 5-point Likert scale and a 100 mm visual analogue scale. Least square mean values were generated and one-tailed t-tests were performed.

Results: After a single dose of ranitidine 150 mg, time to pain with oesophageal acid infusion was increased by 29% (P < 0.05) and visual analogue scale and Likert scores were decreased by 20% (P < 0.06) and 23% (P < 0.02), respectively compared with placebo. After 1 week of ranitidine, positive alterations in sensory parameters persisted. Balloon distention sensory parameters were not altered by ranitidine.

Conclusions: Ranitidine significantly decreased oesophageal sensitivity to acid. Failure of ranitidine to improve balloon sensory parameters supports existence of multiple sensory pathways in the oesophagus.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Double-Blind Method
  • Esophagus / drug effects
  • Female
  • Gastric Acid / physiology*
  • Heartburn / drug therapy*
  • Histamine H2 Antagonists / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Ranitidine / administration & dosage*
  • Treatment Outcome

Substances

  • Histamine H2 Antagonists
  • Ranitidine